Core Scientific (CORZW) Cash & Current Investments (2021 - 2026)

Core Scientific has reported Cash & Current Investments for 6 years, with the latest figure at $1.9 billion in Q2 2026.

• Quarterly Cash & Current Investments rose 232.93% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (up 232.93% YoY) and the FY2025 annual result came in at $311.4 million, down 62.8% from the prior year.
• Cash & Current Investments grew to $1.9 billion in Q2 2026 per CORZW's latest filing, from $1.1 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $1.9 billion in Q2 2026 and troughed at $52.2 million in Q4 2022.
• A 5-year average of $415.4 million and a median of $274.0 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 18181.06% in 2022, then slumped 81.54% in 2023.
• Over 5 years, Cash & Current Investments stood at $52.2 million in 2022, then surged by 33.44% to $69.7 million in 2023, then jumped by 1100.68% to $837.0 million in 2024, then slumped by 62.8% to $311.4 million in 2025, then soared by 521.59% to $1.9 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.9 billion, $1.1 billion, and $311.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.